VECCHIATO, ANTONELLA
 Distribuzione geografica
Continente #
NA - Nord America 1.606
EU - Europa 252
AS - Asia 100
SA - Sud America 2
AF - Africa 1
Totale 1.961
Nazione #
US - Stati Uniti d'America 1.606
IT - Italia 109
CN - Cina 80
SE - Svezia 55
FI - Finlandia 30
DE - Germania 20
GB - Regno Unito 13
IN - India 13
UA - Ucraina 10
SG - Singapore 5
IE - Irlanda 4
FR - Francia 3
BR - Brasile 2
NL - Olanda 2
BE - Belgio 1
HK - Hong Kong 1
HU - Ungheria 1
MD - Moldavia 1
RO - Romania 1
SI - Slovenia 1
SM - San Marino 1
TN - Tunisia 1
UZ - Uzbekistan 1
Totale 1.961
Città #
Fairfield 261
Chandler 222
Ann Arbor 154
Ashburn 143
Woodbridge 119
Seattle 91
Cambridge 88
Houston 84
Wilmington 72
Padova 35
San Diego 35
Jacksonville 34
Beijing 32
Princeton 28
Helsinki 19
Roxbury 19
Medford 17
New York 16
Boardman 12
Des Moines 11
Nanjing 10
London 7
Milan 6
Guangzhou 5
Illasi 5
Singapore 5
Pune 4
Grafing 3
Jinan 3
Los Angeles 3
Nanchang 3
Redwood City 3
Rome 3
Vicenza 3
Vigonza 3
Washington 3
Agordo 2
Bergamo 2
Carpi 2
Chicago 2
Coimbatore 2
Hefei 2
Hounslow 2
Lanzhou 2
Lugo 2
Menlo Park 2
Napoli 2
Natal 2
Norwalk 2
Ogden 2
Orange 2
Oviedo 2
Pieve di Cento 2
Shenyang 2
Sovizzo 2
Tianjin 2
Torreglia 2
Tricesimo 2
Bologna 1
Brussels 1
Budapest 1
Chiswick 1
Costabissara 1
Cremona 1
Dublin 1
Falkenstein 1
Groningen 1
Gunzenhausen 1
Hebei 1
Kharkiv 1
Kilburn 1
Kunming 1
Lappeenranta 1
Legnaro 1
Miami Beach 1
Monza 1
Munich 1
New Delhi 1
Novara 1
Ostuni 1
Palermo 1
Pasian di Prato 1
Pignone 1
Portland 1
Santa Clara 1
Shanghai 1
Stockholm 1
Tashkent 1
Teramo 1
Veneto 1
Zhengzhou 1
Totale 1.638
Nome #
Estimation of Direct Melanoma-related Costs by Disease Stage and by Phase of Diagnosis and Treatment According to Clinical Guidelines 185
Bleomycin-Based Electrochemotherapy: Clinical Outcome from a Single Institution's Experience with 52 Patients. 125
Health Outcomes and Direct Healthcare Costs in Patients with Melanoma: Associations with Level of Education 119
Cost-effectiveness of a melanoma screening programme using whole disease modelling 118
Prognostic factors in merkel cell carcinoma: A retrospective single-center study in 90 patients 105
Estimation of direct costs of melanoma in the Veneto Region: a budget assessment and cost-consequence analysis 101
The role of preoperative ultrasound scan in detecting lymph node metastasis before sentinel node biopsy in melanoma patients 100
Multiple primary melanomas (MPMs) and criteria for genetic assessment: MultiMEL, a multicenter study of the Italian Melanoma Intergroup 91
Sun exposure and melanoma prognostic factors 90
The impact of ultrasound scanning in the staging and follow-up of patients with clinical stage I cutaneous melanoma. 84
Melanoma of Unknown Primary: Evaluation of the Characteristics, Treatment Strategies, Prognostic Factors in a Monocentric Retrospective Study 81
Sarcoma: concordance between initial diagnosis and centralized expert review in a population-based study within three European regions. 79
TERT Promoter Mutations Differently Correlate with the Clinical Outcome of MAPK Inhibitor-Treated Melanoma Patients 73
A Therapeutic and Diagnostic Multidisciplinary Pathway for Merkel Cell Carcinoma Patients 72
Melanoma in Adolescents and Young Adults: Evaluation of the Characteristics, Treatment Strategies, and Prognostic Factors in a Monocentric Retrospective Study 72
Use of an artificial neural network to identify patient clusters in a large cohort of patients with melanoma by simultaneous analysis of costs and clinical characteristics 71
Patient outcome after complete surgery for retroperitoneal sarcoma. 68
Differences in direct costs of patients with stage I cutaneous melanoma: A real-world data analysis 65
Sentinel node biopsy (SNB) and ultrasound (US) scanning in cutaneous melanoma: Technical and clinical considerations 64
Altitude Effect on Cutaneous Melanoma Epidemiology in the Veneto Region (Northern Italy): A Pilot Study 46
Sentinel node biopsy and ultrasound scanning in cutaneous melanoma: clinical and technical considerations 45
Sex Differences in Cutaneous Melanoma: Incidence, Clinicopathological Profile, Survival, and Costs 37
Per- and polyfluoroalkyl substances (PFAS) exposure in melanoma patients: a retrospective study on prognosis and histological features 31
Direct Costs of Care for Adults with Soft Tissue Sarcomas: A Population-Based Study 18
Impact of Wide Local Excision on Melanoma Patient Survival: A Population-Based Study 17
Malignant Melanoma: Direct Costs by Clinical and Pathological Profile 15
Cutaneous Melanoma in Alpine Population: Incidence Trends and Clinicopathological Profile 13
Clinical performance indicators for monitoring the management of cutaneous melanoma: a population-based perspective 13
Totale 1.998
Categoria #
all - tutte 8.674
article - articoli 8.674
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.348


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201976 0 0 0 0 0 0 0 0 0 0 42 34
2019/2020298 30 7 5 23 25 22 32 26 29 40 44 15
2020/2021393 22 32 26 17 16 12 11 26 40 95 63 33
2021/2022443 12 44 76 25 38 36 33 43 16 5 34 81
2022/2023394 61 51 12 59 59 43 4 30 35 13 21 6
2023/2024240 20 38 22 20 19 46 25 27 13 10 0 0
Totale 1.998